Torrent Pharma Acquires JB Pharma in Major INR 25,689 Crore Deal | MCap 28,080.46 Cr - Torrent Pharma acquires 46.39% stake in JB Pharma from KKR for INR 11,917 crores (INR 1,600/share). - Mandatory open offer for up to 26% shares at INR 1,639.18/share. - Additional 2.80% equity to be acquired from JB Pharma employees at the same price. - Post-merger, JB Pharma shareholders get 51 Torrent shares for every 100 JB Pharma shares. - Strategic benefits: Strengthens Torrent’s presence in Indian Pharma Market (IPM), access to JB’s chronic segment brands, and entry into CDMO space. - Torrent Pharma’s annual revenue exceeds INR 11,500 crores, with leadership in CV, GI, CNS, and Cosmo-Dermatology. - JB Pharma is a fast-growing player in hypertension, exporting to over 40 countries. - KKR highlights JB Pharma’s transformation under its ownership, setting stage for growth with Torrent.